Preventive and/or Therapeutic Agents for Meniere's Disease

a technology for meniere's disease and treatment agents, applied in the field of prevention and/or treatment agents for meniere's disease, can solve the problems of complex attacks subsequently, inconvenient and troublesome patients' daily lives, and the development of hearing loss from the medium to the advanced stage, and achieve the effect of effective prevention and/or treatment agents
US20070249695A1Inactive Publication Date: 2007-10-25ONO PHARMA CO LTD +1
1 Cites 3 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
ONO PHARMA CO LTD
Publication Date
2007-10-25
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The present invention relates to preventive and / or therapeutic agents for Meniere's disease, which comprise a leukotriene antagonist (such as pranlukast hydrate) as an active ingredient. Leukotriene antagonists (such as pranlukast hydrate) are effective in ameliorating various symptoms, such as hearing impairment, tinnitus, a feeling of fullness in the ear and vertigo, thus being useful as a preventive and / or therapeutic agent for Meniere's disease.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention is concerned with preventive and / or therapeutic agents for Meniere's disease which comprise a leukotriene antagonist as an active ingredient. BACKGROUND ART

[0002] Meniere's disease is a disease characterized by the cardinal symptom of recurrent attacks of vertigo, which attacks are associated with the cochlear symptoms, such as hearing impairment, tinnitus and a feeling of fullness in the ear, etc.

[0003] The symptoms of vertigo occur in a wide variety of different conditions ranging from severe rotary vertigo to swaying or shaking immobile vertigo: one of such symptoms disappears within several minutes or continues for some hours, whereas the other involves repetition of ameliorated and aggravated dizziness over the extended period of time as long as several days. On the other hand, also known is cochlear Meniere's disease, which is associated with repeated appearance or manifestation and disappearance of hearing impairment, tinnitus an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More